Search - Archive ouverte HAL Access content directly

Filter your results

35 Results
Author: personID (integer) : 919116

Membrane-associated Hsp72 from tumor-derived exosomes mediates STAT3-dependent immunosuppressive function of mouse and human myeloid-derived suppressor cells

Fanny Chalmin , Sylvain Ladoire , Grégoire Mignot , Julie Vincent , Mélanie Bruchard et al.
Journal of Clinical Investigation, 2020, ⟨10.1172/JCI40483⟩
Journal articles hal-03030322v1

Gemcitabine plus cisplatin versus chemoradiotherapy in locally advanced biliary tract cancer: Federation Francophone de Cancerologie Digestive 9902 phase II randomised study

J. M. Phelip , V. Vendrely , F. Rostain , Fabien Subtil , J. L. Jouve et al.
European Journal of Cancer, 2014, 50, pp.2975-82
Journal articles hal-02045109v1

STUDY GLYCOLYTIC METABOLISM IN 1H-MRS MONOVOXEL IN THE MOST AGGRESSIVE PART OF 62 GLIOBLASTOMAS BEFORE AND AFTER 18 MONTHS OF TREATMENT

A. Heintz , Salem Boussida , Zuzana Saidak , J. Chombar , Michel Lefranc et al.
Neuro-Oncology, 2019, 21 (3), pp.89. ⟨10.1093/neuonc/noz126.326⟩
Journal articles hal-03598666v1

Nucleoside-Lipid-Based Nanoparticles for Cisplatin Delivery

S. Khiati , D. Luvino , K. Oumzil , B. Chauffert , M. Camplo et al.
ACS Nano, 2011, 5 (11), pp.8649-8655
Journal articles hal-00696838v1

Phase III trial comparing intensive induction chemoradiotherapy (60 Gy, infusional 5-FU and intermittent cisplatin) followed by maintenance gemcitabine with gemcitabine alone for locally advanced unresectable pancreatic cancer. Definitive results of the 2000-01 FFCD/SFRO study

B. Chauffert , F. Mornex , F. Bonnetain , P. Rougier , C. Mariette et al.
Annals of Oncology, 2008, 19 (9), pp.1592-1599
Journal articles hal-00363727v1

Epinephrine enhances penetration and anti-cancer activity of loca cisplatin on rat sub-cutaneous and peritoneal tumors

C. Duvillard , L. Benoit , P. Moretto , J-L. Beltramo , P. Brunet-Lecomte et al.
International Journal of Cancer, 1999, 81, pp.779-784
Journal articles in2p3-00017866v1

Prevalence and profile of cognitive impairment in adult glioma: a sensitivity analysis

Mathieu Boone , Martine Roussel , Bruno Chauffert , Daniel Le Gars , Olivier Godefroy et al.
Journal of Neuro-Oncology, 2016, 129 (1), pp.123-130. ⟨10.1007/s11060-016-2152-7⟩
Journal articles hal-03598682v1

Locally advanced unresectable pancreatic cancer: Induction chemoradiotherapy followed by maintenance gemcitabine versus gemcitabine alone: Definitive results of the 2000-2001 FFCD/SFRO phase III trial

M. Barhoumi , F. Mornex , F. Bonnetain , P. Rougier , C. Mariette et al.
Cancer/Radiothérapie, 2011, 15 (3), pp.182-191
Journal articles hal-00596035v1

Randomized phase II trial of irinotecan and bevacizumab as neo-adjuvant and adjuvant to temozolomide-based chemoradiation compared with temozolomide-chemoradiation for unresectable glioblastoma: final results of the TEMAVIR study from ANOCEF†

B. Chauffert , L. Feuvret , F. Bonnetain , L. Taillandier , Didier Frappaz et al.
Annals of Oncology, 2014, 25 (7), pp.1442 - 1447. ⟨10.1093/annonc/mdu148⟩
Journal articles hal-01626345v1

Estimating optimal dose of twice-weekly gemcitabine for concurrent chemoradiotherapy in unresectable pancreatic carcinoma: mature results of GEMRT-01 phase I trial

Nicolas Girard , F. Mornex , Nadine Bossard , M. Ychou , B. Chauffert et al.
International Journal of Radiation Oncology, Biology, Physics, 2010, 77(5), pp.1426-1432
Journal articles hal-00698359v1

INTEGRIN A5 IS A POOR PROGNOSTIC FACTOR IN PATIENTS WITH GLIOBLASTOMA TREATED BY THE STUPP PROTOCOL

N. Etienne-Selloum , J. Prades , D. Bello Roufai , F. El Azumi , Mathieu Boone et al.
Neuro-Oncology, 2019, 21 (3), pp.97. ⟨10.1093/neuonc/noz126.357⟩
Journal articles hal-03598665v1

STUDY OF GLUTAMINERGIC AND GLUTAMATERGIC METABOLISM IN 1H-MRS MONOVOXEL IN THE MOST AGGRESSIVE PART OF 62 GLIOBLASTOMA BEFORE AND AFTER 18 MONTHS TREATMENT

A. Heintz , J. Chombar , Salem Boussida , Zuzana Saidak , Michel Lefranc et al.
Neuro-Oncology, 2019, 21 (3), pp.89. ⟨10.1093/neuonc/noz126.327⟩
Journal articles hal-03598667v1

Molecular targeted therapies (MTT) in advanced chordoma (AC) patients (pts).

Loic Lebellec , Axel Le Cesne , Nicolas Penel , Jean -Yves Blay , Christine Chevreau et al.
Journal of Clinical Oncology, 2016, 34 (15, S), ⟨10.1200/JCO.2016.34.15\_suppl.11020⟩
Journal articles hal-03598684v1

Microanalysis of platinum in tumor nodules after cisplatin treatment with different modes of local administration

P. Moretto , C. Duvillard , L. Benoit , B. Chauffert , C. Michelet et al.
Nuclear Instruments and Methods in Physics Research Section B: Beam Interactions with Materials and Atoms, 1999, 158, pp.368-374
Journal articles in2p3-00017831v1
Image document

Iron deficiency in patients with cancer: a prospective cross-sectional study

Elisabeth Luporsi , Anthony Turpin , Vincent Massard , Sophie Morin , Bruno Chauffert et al.
BMJ Palliative and supportive care, 2021, bmjspcare-2021-002913. ⟨10.1136/bmjspcare-2021-002913⟩
Journal articles hal-03481037v1

IMPORTANCE OF EARLY SPECTRAL VARIATIONS DURING A LONGITUDINAL 60-MONTH FOLLOW-UP MRI AND 1H-MRS IN 135 TREATED GLIOBLASTOMA PATIENTS

Salem Boussida , A. Heintz , Zuzana Saidak , Michel Lefranc , Antoine Galmiche et al.
Neuro-Oncology, 2019, 21 (3), pp.86-87. ⟨10.1093/neuonc/noz126.316⟩
Journal articles hal-03598664v1

Evaluation of Proton MR Spectroscopy for the Study of the Tongue Tissue in Healthy Subjects and Patients With Tongue Squamous Cell Carcinoma: Preliminary Findings.

Salem Boussida , Yvener François , Adrien Heintz , Zuzana Saidak , Stéphanie Dakpé et al.
Frontiers in Oral Health, 2022, 3, pp.912803. ⟨10.3389/froh.2022.912803⟩
Journal articles hal-03749905v1
Image document

Heavy-Chain Deposition Disease

Pierre Aucouturier , Ahmed A Khamlichi , Guy Touchard , Eve Justrabo , Michel Cogné et al.
New England Journal of Medicine, 1993, 329 (19), pp.1389 - 1393. ⟨10.1056/NEJM199311043291905⟩
Journal articles inserm-01876787v1
Image document

Quoi de neuf dans la prise en charge des tumeurs fibreuses solitaires/hémangiopéricytomes des méninges ?

Marine Lottin , Alexandre Escande , Matthieu Peyre , Henri Sevestre , Claude Alain Maurage et al.
Bulletin du Cancer, 2020, 107, pp.1260 - 1273. ⟨10.1016/j.bulcan.2020.09.011⟩
Journal articles hal-03492850v1
Image document

Expression Analysis of α5 Integrin Subunit Reveals Its Upregulation as a Negative Prognostic Biomarker for Glioblastoma

Nelly Etienne-Selloum , Julien Prades , Diana Bello-Roufai , Mathieu Boone , Henri Sevestre et al.
Pharmaceuticals, 2021, 14 (9), pp.882. ⟨10.3390/ph14090882⟩
Journal articles hal-03436842v1

RETROSPECTIVE ANALYSIS OF LONG-TERM RESPONSE TO BEVACIZUMAB IN COMBINATION WITH IRINOTECAN FOR RECURRENT GLIOBLASTOMA: IDENTIFICATION OF PROGNOSTIC FACTORS

C. Besson , M. Morisse , H. Brut , W. Waissi , G. Noel et al.
Neuro-Oncology, 2019, 21 (3), pp.98. ⟨10.1093/neuonc/noz126.360⟩
Journal articles hal-03598663v1

Intracranial Solitary Fibrous Tumour Management: A French Multicentre Retrospective Study

Marine Lottin , Alexandre Escande , Luc Bauchet , Marie Albert-Thananayagam , Maël Barthoulot et al.
Cancers, 2023, 15 (3), pp.704. ⟨10.3390/cancers15030704⟩
Journal articles hal-03991379v1

Advanced chordoma treated by first-line molecular targeted therapies: Outcomes and prognostic factors. A retrospective study of the French Sarcoma Group (GSF/GETO) and the Association des Neuro-Oncologues d'Expression Française (ANOCEF)

Loïc Lebellec , Bruno Chauffert , Jean-Yves Blay , Axel Le Cesne , Christine Chevreau et al.
European Journal of Cancer, 2017, 79, pp.119 - 128. ⟨10.1016/j.ejca.2017.03.037⟩
Journal articles hal-01655981v1
Image document

Membrane-associated Hsp72 from tumor-derived exosomes mediates STAT3-dependent immunosuppressive function of mouse and human myeloid-derived suppressor cells.

Fanny Chalmin , Sylvain Ladoire , Grégoire Mignot , Julie Vincent , Mélanie Bruchard et al.
Journal of Clinical Investigation, 2010, 120 (2), pp.457-71. ⟨10.1172/JCI40483⟩
Journal articles inserm-00451697v1

High Intra-abdominal Pressure Enhances the Penetration and Antitumor Effect of Intraperitoneal Cisplatin on Experimental Peritoneal Carcinomatosis

P. Esquis , D. Consolo , G. Magnin , P. Pointaire , P. Moretto et al.
Annals of Surgery, 2006, 244, pp.106-112. ⟨10.1097/01.sla.0000218089.61635.5f⟩
Journal articles in2p3-00311721v1

Blood baseline neutrophil count predicts bevacizumab efficacy in glioblastoma

Aurélie Bertaut , Caroline Truntzer , Rachid Madkouri , Coureche Guillaume Kaderbhai , Valentin Derangère et al.
Oncotarget, 2016, 7 (43), pp.70948-70958. ⟨10.18632/oncotarget.10898⟩
Journal articles hal-01410048v1

Probing Tumour Proteostasis and the UPR with Serum Markers

Antoine Galmiche , Chloé Sauzay , Aline Houessinon , Bruno Chauffert , Olivier Pluquet et al.
Trends in Cancer, 2016, 2 (5), pp.219-221. ⟨10.1016/j.trecan.2016.04.004⟩
Journal articles hal-03598685v1

Long-term survival in patients with recurrent glioblastoma treated with bevacizumab: a multicentric retrospective study

Mony Chenda Morisse , Nelly Etienne-Selloum , Diana Bello-Roufai , Marie Blonski , Luc Taillandier et al.
Journal of Neuro-Oncology, 2019, 144 (2), pp.419-426. ⟨10.1007/s11060-019-03245-5⟩
Journal articles hal-03024714v1

Alpha-fetoprotein is a biomarker of unfolded protein response and altered proteostasis in hepatocellular carcinoma cells exposed to sorafenib

Aline Houessinon , Albane Gicquel , Flora Bochereau , Christophe Louandre , Remy Nyga et al.
Cancer Letters, 2016, 370 (2), pp.242-249. ⟨10.1016/j.canlet.2015.10.032⟩
Journal articles hal-03592366v1

Minimal clinically important difference for the EORTC QLQ-C30 and QLQ-BN20 questionnaires in glioblastoma patients using several distribution and anchor-based methods

Ahmad Ousmen , Amelie Anota , Bruno Chauffert , Loic Feuvret , Luc Taillandier et al.
24th Annual Conference of the International Society for Quality of Life Research, Oct 2017, Philadelphia, Pennsylvania, United States. ⟨10.1007/s11136-017-1658-6⟩
Conference papers hal-03598677v1